# Neostigmine methylsulfate

NDC: 71839-105
Generic name: Neostigmine methylsulfate
Labeler / Manufacturer: BE Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20190513

FDA application: ANDA212512

## Active ingredients

- NEOSTIGMINE METHYLSULFATE: .5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71839-105"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71839-105
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=971713db-d5ac-44c1-ada5-a56a943d79bf